Search results for "interval"

showing 10 items of 1703 documents

Prenatal head growth and child neuropsychological development at age 14 months

2014

We sought to assess the association between prenatal head growth and child neuropsychological development in the general population.We evaluated 2104 children at the age of 14 months from a population-based birth cohort in Spain. Head circumference (HC) was measured by ultrasound examinations at weeks 12, 20, and 34 of gestation and by a nurse at birth. Head growth was assessed using conditional SD scores between weeks 12-20 and 20-34. Trained psychologists assessed neuropsychological functioning using the Bayley Scales of Infant Development. Head size measurements at birth were transformed into a 3-category variable: microcephalic (10th percentile), normocephalic (≥10th and90th percentile)…

AdultMalePediatricsmedicine.medical_specialtyPopulationBayley Scales of Infant DevelopmentUltrasonography PrenatalCohort StudiesChild DevelopmentCognitionPregnancymedicineHumanseducationPsychomotor learningPregnancyeducation.field_of_studybusiness.industryInfant NewbornInfantObstetrics and GynecologyOrgan Sizemedicine.diseaseChild developmentMegalencephalyConfidence intervalMicrocephalyGestationFemalebusinessHeadCohort studyAmerican Journal of Obstetrics and Gynecology
researchProduct

Migraine history and migraine-induced stroke in the Dijon stroke registry.

1999

Two thousand three hundred and eighty-nine patients with first-ever stroke were registered in the population-based Dijon Stroke Registry over an 11-year period. There was a history of migraine in 49 cases (2%), with a majority of women (2.8% versus 1.1% men) with the following distribution: 27 cases among 1,380 large-artery cerebral infarctions (1.9%), 6 cases among 358 small-artery cerebral infarctions (1.6%), 6 cases among 412 cerebral infarctions due to cardiac embolism (1.4%), 7 cases among 191 cerebral hemorrhages (3.6%) and 3 cases among 47 subarachnoid hemorrhages (6.3%). The male/female ratio was 0.58 for the 49 strokes with a history of migraine versus 1.27 for the 2,340 strokes wi…

AdultMalePediatricsmedicine.medical_specialtyStroke registryAdolescentEpidemiologyMigraine DisordersPopulationInfarctionCatchment Area HealthRecurrenceRisk FactorsEpidemiologyMedicineHumanscardiovascular diseasesProspective StudiesRegistrieseducationStrokeeducation.field_of_studybusiness.industryIncidence (epidemiology)Middle Agedmedicine.diseaseConfidence intervalCerebrovascular DisordersMigraineCommunity MedicineAnesthesiaPopulation SurveillanceFemaleNeurology (clinical)FrancebusinessNeuroepidemiology
researchProduct

Does intensive multimodal treatment for maternal ADHD improve the efficacy of parent training for children with ADHD? A randomized controlled multice…

2015

Background This is the first randomized controlled multicenter trial to evaluate the effect of two treatments of maternal attention-deficit hyperactivity disorder (ADHD) on response to parent–child training targeting children's external psychopathology. Methods Mother–child dyads (n = 144; ADHD according to DSM-IV; children: 73.5% males, mean age 9.4 years) from five specialized university outpatient units in Germany were centrally randomized to multimodal maternal ADHD treatment [group psychotherapy plus open methylphenidate medication; treatment group (TG): n = 77] or to clinical management [supportive counseling without psychotherapy or psychopharmacotherapy; control group (CG): n = 67].…

AdultMalePediatricsmedicine.medical_specialtymedicine.medical_treatmentMothersChild Behavior DisordersGroup psychotherapyMaintenance therapyMulticenter trialOutcome Assessment Health CareDevelopmental and Educational PsychologymedicineHumansChildAdverse effectMethylphenidateMiddle AgedCombined Modality TherapyConfidence intervalPsychiatry and Mental healthAttention Deficit Disorder with HyperactivityPediatrics Perinatology and Child HealthMethylphenidatePsychotherapy GroupParent trainingCentral Nervous System StimulantsFamily TherapyFemalePsychologyPsychopathologymedicine.drugClinical psychologyJournal of Child Psychology and Psychiatry
researchProduct

Establishing the upper reference limit of Galectin-3 in healthy blood donors

2017

Introduction Galectin-3 (Gal-3) is an independent predictor of poor outcomes and mortality in patients with heart failure (HF). Thus, it has been proposed as a reliable prognostic biomarker for HF. The definition of reference intervals is mandatory for interpreting the findings of experimental studies and encouraging the routine use of biomarkers in clinical practice. To date, no study assessed the reference intervals of Gal-3 and identified the biological variables that affect its concentration in a well-defined healthy population. The aim of this study was to determine the upper reference limit (URL) of Gal-3 in a highly reliable population of healthy subjects. Materials and methods We re…

AdultMalePercentilemedicine.medical_specialtyBlood donorAdolescentGalectin 3PopulationClinical BiochemistryBlood DonorsHeart failure030204 cardiovascular system & hematologyYoung Adult03 medical and health sciences0302 clinical medicineInternal medicineNatriuretic Peptide BrainmedicineHumansGalectin-3Prognostic biomarkergalectin-3; blood donors; heart failure; reference values; upper reference limit (URL)educationAgedImmunoassayeducation.field_of_studybusiness.industryHealthy populationTroponin IBiochemistry (medical)Healthy subjectsMiddle Agedreference valuesmedicine.diseaseOriginal PapersHealthy VolunteersReference intervals030220 oncology & carcinogenesisHeart failurePopulation studyFemaleUpper reference limit (URL)businessBiomarkersReference valueGlomerular Filtration Rate
researchProduct

Comparison of the 45-Second/15-Second Intermittent Running Field Test and the Continuous Treadmill Test

2012

Purposes:To compare the physiological responses and maximal aerobic running velocity (MAV) during an incremental intermittent (45-s run/15-s rest) field test (45-15FIT) vs an incremental continuous treadmill test (TR) and to demonstrate that the MAV obtained during 45-15FIT (MAV45-15) was relevant to elicit a high percentage of maximal oxygen uptake (VO2max) during a 30-s/30-s intermittent training session.Methods:Oxygen uptake (VO2), heart rate (HR), and lactate concentration ([La]) were measured in 20 subjects during 2 maximal incremental tests and four 15-min intermittent tests. The time spent above 90% and 95% VO2max (t90% and t95% VO2max, respectively) was determined.Results:Maximal ph…

AdultMalePeriodicitymedicine.medical_specialtyTime FactorsAdolescentPhysical Therapy Sports Therapy and RehabilitationInterval trainingRunningYoung AdultOxygen ConsumptionAnimal scienceHeart RateTask Performance and AnalysisHeart ratemedicineHumansOrthopedics and Sports MedicineLactic AcidTreadmillMuscle SkeletalAnalysis of VarianceLactate concentrationbusiness.industryVO2 maxOxygen uptakePhysiological responsesPhysical FitnessExercise TestLinear ModelsPhysical therapyAnalysis of variancebusinessBiomarkersMuscle ContractionInternational Journal of Sports Physiology and Performance
researchProduct

The Disease-Specific Phenotype in Cardiomyocytes Derived from Induced Pluripotent Stem Cells of Two Long QT Syndrome Type 3 Patients

2013

Long QT syndromes (LQTS) are heritable diseases characterized by prolongation of the QT interval on an electrocardiogram, which often leads to syncope and sudden cardiac death. Here we report the generation of induced pluripotent stems (iPS) cells from two patients with LQTS type 3 carrying a different point mutation in a sodium channel Nav1.5 (p.V240M and p.R535Q) and functional characterization of cardiomyocytes (CM) derived from them. The iPS cells exhibited all characteristic properties of pluripotent stem cells, maintained the disease-specific mutation and readily differentiated to CM. The duration of action potentials at 50% and 90% repolarization was longer in LQTS-3 CM as compared t…

AdultMalePluripotent Stem Cellsmedicine.medical_specialtyLong QT syndromeCellular differentiationlcsh:MedicineAction PotentialsNAV1.5 Voltage-Gated Sodium ChannelQT intervalMembrane PotentialsNAV1.5 Voltage-Gated Sodium ChannelInternal medicinemedicineRepolarizationHumansPoint MutationMyocytes CardiacInduced pluripotent stem celllcsh:ScienceCells CulturedMultidisciplinarybusiness.industryPoint mutationSodium channellcsh:RCell Differentiationmedicine.diseaseLong QT SyndromeEndocrinologylcsh:QFemalebusinessResearch ArticlePLoS ONE
researchProduct

Escitalopram causes fewer seizures in human overdose than citalopram

2010

Seizures are a recognized complication of acute overdose with the racemic (1:1 ratio of R- and S-enantiomers) selective serotonin reuptake inhibitor antidepressant citalopram.We tested the hypothesis that escitalopram (the therapeutically active S-enantiomer of citalopram) causes fewer seizures in overdose than citalopram at comparable doses of the S-enantiomer.Multicenter retrospective review of cases with citalopram and escitalopram overdose reported to German, Austrian, and Swiss Poisons Centers between 1997 and 2006.316 citalopram and 63 escitalopram cases were analyzed. Somnolence, nausea, vomiting, tachycardia, QT prolongation, and tremor occurred with similar frequency in both groups…

AdultMalePoison Control CentersAdolescentNauseaSerotonin reuptake inhibitor610 Medicine & healthCitalopramCitalopramToxicologyDrug overdosebehavioral disciplines and activitiesQT intervalYoung AdultSeizuresGermanymental disordersmedicineHumansEscitalopramAgedRetrospective StudiesAged 80 and over3005 ToxicologyStereoisomerismGeneral MedicineMiddle Agedmedicine.disease10199 Clinic for Clinical Pharmacology and ToxicologyAustriaAnesthesiaVomitingAntidepressantFemaleDrug Overdosemedicine.symptomPsychologySelective Serotonin Reuptake InhibitorsSwitzerlandmedicine.drug
researchProduct

Clinical and prognostic value of 18F-FDG-PET/CT in restaging of pancreatic cancer

2018

Aim The aim of this retrospective multicentre study was to evaluate the clinical and prognostic effect of fluorine-18-fluorodeoxyglucose (18F-FDG)-PET/computed tomography (CT) in the restaging process of pancreatic cancer (PC). Materials and methods Data from patients treated for primary PC, who underwent18F-FDG-PET/CT for suspicious of disease progression, were collected. Accuracy was assessed employing conventional diagnostic procedures, multidisciplinary team case notes, further18F-FDG-PET/CT scans and/or follow-up. Receiver operating characteristic curve and likelihood ratio (LR+/-) analyses were used for completion of accuracy definition. Progression-free survival (PFS) and overall sur…

AdultMalePrognosioverall survival18F-FDG-PET/CTpancreatic cancer030218 nuclear medicine & medical imaging03 medical and health sciencesdisease progression0302 clinical medicineRetrospective StudieFluorodeoxyglucose F18Positron Emission Tomography Computed TomographyPancreatic cancerrestagingHumansMedicineRadiology Nuclear Medicine and imagingProgression-free survivalRetrospective StudiesAgedNeoplasm StagingReceiver operating characteristicbusiness.industryProportional hazards modelHazard ratioPancreatic NeoplasmArea under the curveRetrospective cohort studyGeneral MedicineMiddle AgedPrognosismedicine.diseaseConfidence intervalPancreatic Neoplasms030220 oncology & carcinogenesisFemalebusinessNuclear medicineprogression-free survivalHumanNuclear Medicine Communications
researchProduct

Comparing asthma treatment in elderly versus younger patients

2011

SummaryA randomised 6-month study compared two maintenance doses of budesonide/formoterol (Symbicort® Turbuhaler®)hhNeither the Symbicort SMART posology nor the dry powder formulation, Turbuhaler, is currently approved in the US. maintenance and reliever therapy (Symbicort SMART®), 160/4.5 μg 1 × 2 and 2 × 2, in 8053 asthmatics with symptoms despite treatment with inhaled corticosteroids ± inhaled long-acting β2-agonists. This analysis compared response to the two treatments in elderly patients, ≥65 years, with that in younger patients. Elderly patients with early- or late-onset asthma were also compared.Elderly patients had lower post-bronchodilator FEV1 percentage predicted normal at base…

AdultMalePulmonary and Respiratory MedicineBudesonideSymbicort SMARTmedicine.medical_specialtylaw.inventionExacerbationsElderlyRandomized controlled triallawFormoterol FumarateSurveys and QuestionnairesInternal medicineAdministration InhalationmedicineHumansBudesonideBudesonide/formoterolAgedAsthmaACQDose-Response Relationship Drugbusiness.industryHazard ratiomedicine.diseaseConfidence intervalAsthmaBronchodilator AgentsSurgeryTreatment OutcomeBudesonide/formoterolEthanolaminesAsthma Control QuestionnaireDisease ProgressionQuality of LifeDrug Therapy CombinationFemaleFormoterolbusinessmedicine.drugRespiratory Medicine
researchProduct

Treatment Monitoring Program for Implementation of Adherence to Second-Line Erlotinib for Advanced Non–Small-Cell Lung Cancer

2012

Abstract Background Adherence to erlotinib could be a determinant for clinical outcome and treatment toxicity in patients with advanced non–small-cell lung cancer (A-NSCLC). Patients and Methods In an observational study, the Basel Assessment of Adherence Scale (BAAS), a visual analogue scale (VAS), pill counting, and missed appointment rate were used to evaluate adherence in a first cohort of patients who was prescribed erlotinib without a specifically designed management strategy and in a second cohort of patients followed by an oral treatment monitoring program. Results Adherence > 95% by BAAS at 2 months of treatment in the first and second cohorts was 72% and 84%, respectively ( P = .0…

AdultMalePulmonary and Respiratory MedicineCancer Researchmedicine.medical_specialtyLung NeoplasmsVisual analogue scaleAdenocarcinomaMedication AdherenceErlotinib HydrochlorideCarcinoma Non-Small-Cell LungInternal medicinemedicineHumansErlotinib HydrochlorideProtein Kinase InhibitorsSurvival rateAgedNeoplasm StagingRetrospective StudiesAged 80 and overSalvage Therapybusiness.industryHealth Plan ImplementationRetrospective cohort studyAdenocarcinoma Bronchiolo-AlveolarMiddle AgedPrognosisSmall Cell Lung CarcinomaMonitoring programConfidence intervalSurgerySurvival RateOncologyCohortQuinazolinesCarcinoma Large CellPatient ComplianceFemaleErlotinibDrug MonitoringbusinessFollow-Up Studiesmedicine.drugClinical Lung Cancer
researchProduct